Performed a landscape analysis for a Fortune 500 company in the vaccine/LNP space.
Performed an IP diligence for a gene therapy company that helped the client obtain ~$75 million in early series financing.
Patent portfolio management
Actively counsels clients on strategic management of complex patent portfolios related to medical device instruments.
IP due diligence for acquisition
Completed an IP due diligence for a major acquisition by a Fortune 500 client in the immunotherapeutic space.
'Life Sciences CEO Forum,' December 2020, Boston, MA (presenter)
'Patents 101: Protecting Innovations,' December 2019, New Orleans, LA (presenter)
'The World of Gene Therapy Intellectual Property,' April 2018, Boston, MA (presenter)
'Obviousness-type Double Patenting Rejections,' November 2017, Boston, MA (presenter)
'The World of Bispecific Antibody Intellectual Property,' September 2017, Boston, MA (presenter)
'IP Issues When Exporting to the U.S. & Strategies for U.S. Patent Disputes,' August 2017, Qingdao, China (presenter)
'Securing Intellectual Property Patent Rights in the United States,' August 2017, Beijing, China (presenter)
'Patent Transparency & Improvement Act: Come Take a Troll with Me,' March 2014, Boston, MA (presenter)
'Considerations for Universities Claiming Micro-entity Status,' August 2013, Boston, MA (presenter)